Get the Stockscreener App
3.59
3.16%
0.11
After Hours:
3.50
-0.09
-2.51%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $3.59, with a volume of 92,826.
It is up +3.16% in the last 24 hours and up +0.00% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$3.48
Open:
$3.4
24h Volume:
92,826
Relative Volume:
0.75
Market Cap:
$3.84M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-7.8043
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
+6.53%
1M Performance:
+0.00%
6M Performance:
-67.02%
1Y Performance:
-91.02%
1-Day Range:
$3.40
$3.68
1-Week Range:
$3.20
$3.68
52-Week Range:
$3.00
$56.25
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
3.59 | 3.69M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Should you hold or exit Shuttle Pharmaceuticals Holdings Inc. nowWall Street Watch & Real-Time Chart Breakout Alerts - Newser
Will Shuttle Pharmaceuticals Holdings Inc. continue its uptrendQuarterly Trade Review & Community Consensus Trade Alerts - Newser
Advanced analytics toolkit walkthrough for Shuttle Pharmaceuticals Holdings Inc.2025 Support & Resistance & Low Risk High Reward Trade Ideas - Newser
Long term hold vs stop loss in Shuttle Pharmaceuticals Holdings Inc.Gold Moves & Safe Capital Allocation Plans - Newser
Ranking Shuttle Pharmaceuticals Holdings Inc. among high performing stocks via tools2025 Price Action Summary & Low Risk Entry Point Tips - Newser
Is Shuttle Pharmaceuticals Holdings Inc. stock ready for a breakoutJuly 2025 Institutional & Verified Short-Term Plans - Newser
Visual trend scoring systems applied to Shuttle Pharmaceuticals Holdings Inc.Weekly Profit Recap & Stock Market Timing Techniques - Newser
Visual analytics tools that track Shuttle Pharmaceuticals Holdings Inc. performanceQuarterly Profit Report & Free Technical Pattern Based Buy Signals - Newser
How to interpret RSI for Shuttle Pharmaceuticals Holdings Inc. stock2025 Big Picture & Scalable Portfolio Growth Methods - Newser
Real time pattern detection on Shuttle Pharmaceuticals Holdings Inc. stockSwing Trade & Free Weekly Watchlist of Top Performers - Newser
Chart based analysis of Shuttle Pharmaceuticals Holdings Inc. trendsIPO Watch & Short-Term Swing Trade Alerts - Newser
Applying Wyckoff theory to Shuttle Pharmaceuticals Holdings Inc. stockPortfolio Gains Summary & Daily Chart Pattern Signals - Newser
How hedge fund analytics apply to Shuttle Pharmaceuticals Holdings Inc. stockJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser
Is this a good reentry point in Shuttle Pharmaceuticals Holdings Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - Newser
Is Shuttle Pharmaceuticals Holdings Inc. still worth holding after the dip2025 Price Targets & Safe Entry Trade Signal Reports - Newser
What candlestick patterns are forming on Shuttle Pharmaceuticals Holdings Inc.Weekly Trend Summary & Fast Moving Trade Plans - Newser
Can volume confirm reversal in Shuttle Pharmaceuticals Holdings Inc.July 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
Shuttle Pharmaceuticals Holdings Inc.’s volatility index tracking explainedMarket Rally & AI Enhanced Execution Alerts - Newser
Will earnings trigger a reversal in Shuttle Pharmaceuticals Holdings Inc.Layoff News & Stock Timing and Entry Methods - Newser
Is Shuttle Pharmaceuticals Holdings Inc. reversing from oversold territory2025 Price Targets & Verified Chart Pattern Signals - Newser
Will Shuttle Pharmaceuticals Holdings Inc. benefit from rising consumer demandJuly 2025 Trends & Long-Term Growth Stock Strategies - Lancaster City Council
Growth Value: Can Shuttle Pharmaceuticals Holdings Inc. stock outperform in a bear market2025 Fundamental Recap & Trade Opportunity Analysis - Lancaster City Council
Custom watchlist performance reports with Shuttle Pharmaceuticals Holdings Inc.July 2025 Update & Consistent Return Strategy Ideas - Newser
What is Shuttle Pharmaceuticals Holdings Inc.’s market position2025 Price Action Summary & Reliable Intraday Trade Plans - beatles.ru
Shuttle Pharmaceuticals Appoints Adam Chambers as Director - MSN
Shuttle Pharmaceuticals appoints Adam Chambers to board of directors By Investing.com - Investing.com Australia
Shuttle Pharmaceuticals appoints Adam Chambers to board of directors - Investing.com
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):